Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Ruiying Pioneer Pharmaceutical is a large-scale Chinese pharmaceutical company specializing in the research, development, and manufacturing of anti-infective agents, particularly cephalosporin antibiotics. The company operates as a key subsidiary of the Ruiying Group and maintains a comprehensive industrial chain that spans from pharmaceutical intermediates and active pharmaceutical ingredients (APIs) to finished dosage forms. Their product portfolio includes a wide range of well-known antibiotics such as ceftriaxone, cefotaxime, and cefazolin, serving both domestic and international markets. Beyond manufacturing its own branded products, the company provides contract manufacturing and development services to global partners. Shandong Ruiying Pioneer Pharmaceutical is recognized for its significant production capacity and adherence to international quality standards, including GMP certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Ruiying Pioneer Pharmaceutical.